- €25.86bn
- €58.14bn
- €47.64bn
- 34
- 64
- 28
- 34
Annual cashflow statement for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,430 | -15,561 | 1,022 | 4,166 | -2,942 |
| Depreciation | |||||
| Non-Cash Items | 899 | 1,198 | 795 | 521 | 1,898 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -507 | 6,000 | 255 | -4,094 | -3,859 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8,187 | 4,896 | 5,128 | 7,096 | 5,117 |
| Capital Expenditures | -2,650 | -2,418 | -2,611 | -2,949 | -2,751 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,979 | -1,655 | 3,466 | 568 | -766 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -671 | -4,073 | 855 | -2,381 | -3,517 |
| Financing Cash Flow Items | -1,478 | -1,276 | -1,200 | -1,251 | -1,552 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8,389 | 423 | -5,645 | -4,220 | -679 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -867 | 1,006 | 373 | 607 | 736 |